{
    "title": "Combining two precision medicines may treat drug-resistant cancers - study",
    "url": "https://www.dailymail.co.uk/wires/pa/article-8733007/Combining-two-precision-medicines-treat-drug-resistant-cancers--study.html",
    "date": "2020-09-14",
    "keywords": [
        "cancer",
        "combination",
        "study",
        "drug",
        "trial",
        "olaparib",
        "medicine",
        "research",
        "icr",
        "treatment",
        "precision",
        "prostate",
        "capivasertib",
        "dna",
        "royal",
        "marsden",
        "nhs",
        "foundation",
        "trust",
        "number",
        "professor",
        "attack",
        "breast",
        "time",
        "system",
        "addiction",
        "molecule",
        "akt",
        "tumour",
        "growth",
        "earlystage",
        "team",
        "institute",
        "london",
        "variety",
        "daviespa",
        "leader",
        "johann",
        "consultant",
        "oncologist",
        "potential",
        "benefit",
        "laterstage",
        "phase",
        "twentyfive",
        "resistant",
        "brca",
        "paul",
        "workman",
        "executive",
        "possibility",
        "option",
        "discovery",
        "journal",
        "company",
        "astrazeneca",
        "centre",
        "alliance"
    ],
    "category": [
        "wires",
        "pa"
    ]
}